Stock Ratings / Health Care / UFPT / dividends

INSP (66) LMAT (69) XRAY (32) KMTS (50) ⌘ Pro Terminal →

UFP Technologies Inc. (UFPT) Dividend Safety Gauge & 10-Year DRIP Compounder

$284.50 -3.00% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $283.65

UFP Technologies Inc. (UFPT) earns a Roarable Rating of B+ (Buy) with 77/100 RQD Confidence. High-quality cash engine (28% profit margin, 14% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 77/100 (B+) historically ranked in the Top 10% of excess returns over the next 90 days (+7.8% avg 90D alpha vs SPY • 70.3% hit rate) →

ROARABLE B+ • BUY Cap $2.27B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on UFPT Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is UFPT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, UFP Technologies Inc. (NASDAQ: UFPT) is rated B+ (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 77/100 at a spot price of $284.50 (-3.00% 1D, market cap $2.27B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 13/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 14/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, UFPT ranks #30 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does UFPT compare to INSP and LMAT in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), UFPT carries a Roarable B+ (77/100 RQD), trailing P/E of 33.3x, gross margin of 28.3%, and ROIC of 13.9%. By comparison, INSP (Inspire Medical Systems Inc.) holds a C+ grade (66/100 RQD, P/E 14.2x, ROIC 6.0%, cap $2.06B) and LMAT (LeMaitre Vascular Inc.) posts a C+ grade (69/100 RQD, P/E 33.8x, ROIC 14.7%, cap $1.95B). Among the 5-stock peer group, INSP leads on earnings multiple (14.2x) while LMAT leads on capital efficiency (14.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for UFPT?

▼

Per UFPT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000914156), UFP Technologies Inc. generated $602.8M in revenue (+19.5% YoY), $68.3M in net income, and $91.9M in free cash flow against $655.1M in total assets and $123.0M in total debt. Key quantitative strengths: Strong cash generator (28% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $283.65 (-0.30%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 15.2% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 77/100 (B+) historically ranked in the Top 10% of excess returns over the next 90 days (+7.8% avg 90D alpha vs SPY • 70.3% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B+

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+8.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for UFPT)Realized 20D OHLCV Swing Band: ±7%

Deterministic 5-Pillar Attribution (77/100 Composite)

🔍 WHY UFPT SCORES 77/100 (B+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (23% of score)

Altman Z-Score 8.31 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9

▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 15.2% FCF Margin ($91.9M FCF) & 28.3% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning13/20 pts (-7 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-7 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade A$295.82-0.9% Next Q

Q2 (-2Q)

Grade A$293.25-0.7% Next Q

Q3 (-1Q)

Grade A-$291.28-2.3% Next Q

Current

Grade B+$284.50+7.8% Hist 90D α

Trajectory: A (85) → B+ (77)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the UFPT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 77/100 (B+) score, UFPT faces multiple-compression risk if 33.3x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 25.8% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($291.41) or 200D SMA ($249.44) invalidates the momentum regime and cuts Target Base ($308.82) toward Bear Floor ($233.29).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $UFPT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “UFPT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 77%NO 23%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (12.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $32,473

Est. Year-10 Shareholder Yield: $585/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.3K

Yr 1

$12.7K

Yr 2

$14.2K

Yr 3

$16.0K

Yr 4

$18.0K

Yr 5

$20.3K

Yr 6

$22.8K

Yr 7

$25.7K

Yr 8

$28.9K

Yr 9

$32.5K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in UFPT & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on UFPT and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

UFPT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +47.75%⚡ TESTING RESISTANCE

2026-11-02O $286.0H $293.3L $284.5C $284.5VOL 107.6K

RES: $297.8SUP: $278.7SMA50: $291.4SMA200: $249.4

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UFPT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 UFPT Butterfly Map → + Track UFPT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

25.7%/yr Implied 5Y Growth

vs. +19.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on UFPT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for UFPT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for UFPT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (UFPT)

Health Care Rank #30 of 1016 ⚔️ INSP vs UFPT Full Matrix →

1. Head-to-Head Health Care Peer Comparison (UFPT vs. INSP, LMAT, XRAY, KMTS)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, UFP Technologies Inc. (UFPT) ranks #30 by composite RQD confidence (77/100, grade B+) and #238 by equity capitalization ($2.27B). Within this direct 5-issuer industry benchmark cohort, INSP leads on earnings valuation at 14.2x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. UFPT currently leads its immediate peer cohort in composite quantitative strength at 77/100 (B+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
UFPT ACTIVE UFP Technologies Inc.	B+	77/100	33.3x	28.3%	13.9%	-3.00%	$2.27B	Benchmark Subject
INSP Inspire Medical Systems Inc.	C+	66/100	14.2x	85.4%	6.0%	-4.33%	$2.06B	/insp-vs-ufpt →
LMAT LeMaitre Vascular Inc.	C+	69/100	33.8x	71.5%	14.7%	-5.08%	$1.95B	/lmat-vs-ufpt →
XRAY DENTSPLY SIRONA Inc.	E	32/100	—	50.0%	-11.0%	-0.83%	$1.92B	/xray-vs-ufpt →
KMTS Kestra Medical Technologies Ltd.	D	50/100	—	51.4%	-35.0%	-3.01%	$1.82B	/kmts-vs-ufpt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000914156

In its most recent audited fiscal period (FY2025, filed 2025-12-31), UFP Technologies Inc. (UFPT) reported GAAP revenue of $602.8M (+19.5% vs. FY2024 revenue of $504.4M , and +50.7% cumulative change since FY2023) , GAAP net income of $68.3M, operating cash flow of $91.9M, and free cash flow of $91.9M (+61.4% YoY). On the balance sheet, UFPT closed FY2025 with $655.1M in total assets against $123.0M in total debt (Altman Z-Score: 8.31, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$602.8M	$68.3M	$91.9M	$91.9M	$655.1M	$123.0M
FY2024 (FY)	2024-12-31	$504.4M	$59.0M	$66.6M	$56.9M	$629.0M	$176.9M
FY2023 (FY)	2023-12-31	$400.1M	$44.9M	$41.3M	$41.3M	—	—

3. UFPT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is UFPT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does UFPT compare to INSP and LMAT in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for UFPT?

Where is UFPT trading relative to its 50-day, 200-day, and 52-week technical levels?

UFPT last traded at $284.50 (-3.00% on volume of 85,423 shares), positioning the stock -2.37% below its 50-day simple moving average ($291.41) and +14.06% above its 200-day simple moving average ($249.44). Across its 52-week range of $173.86 to $338.71, UFPT sits at the 67.1% percentile with a 14-day RSI of 51.0 (NEUTRAL RANGE) and an implied next-earnings move of ±7.0% ($264.59 to $304.41).

UFPT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does UFPT pay a dividend and is it safe?

UFP Technologies Inc. (UFPT) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: UFPT RQD Cockpit UFPT 12M Forecast UFPT Earnings & Move UFPT Dividends & DRIP UFPT Insiders & 13F UFPT Whale Options UFPT Profit Sankey UFPT News & Why